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ABSTRACT 
In this paper, the current state of in-silico, B-cell epitope 
prediction is discussed.   Recommendations for improving some 
of the approaches encountered are outlined, along with the 
presentation of an entirely novel technique, which uses molecular 
mechanics for epitope classification, evaluation and prediction. 
INTRODUCTION 
The relatively new field of immunomics, which focuses on the 
interactions between a pathogen and a host, erects a bridge across 
the endeavors of informatics, genomics, proteomics, immunology 
and clinical medicine. 
Genomics and proteomics have both arisen to become 
independent arenas for research and development whist 
immunomics is lagging in this effort (De Groot 2006). 
Perhaps part of the issue is that many immunologists prefer 
traditional approaches to solving biological problems, believing 
that ‘hands-on’ results are somehow more significant than in-
silico techniques.9   
Thus one finds that the computational tools available for the 
genome researcher have reached a level of maturity and 
recognition that an immunologist can only admire. 
The average immunologist is overwhelmed with a broad array of 
tools that are often highly specific in use, are not well understood 
nor characterized, have undergone fairly limited testing, and are 
often not publicly accessible.9 
Despite the relative immaturity of the current suite of tools, 
advances in the area of vaccine design have shown some early 
success (Korber et. al 2006).   
As immunoinformatics tools begin to mature and see wider 
adoption, there are numerous opportunities for applying these 
techniques; problems in protein therapeutics, autoimmunity, 
transplantation and allergy to name a few. 
IMMUNE RESPONSE 
In order to discuss the computational basis for many of the 
immunoinformatics tools, an appreciation of the biology involved 
in the immune response must first be elaborated. 
The underlying goal of any immune response is to remove disease 
causing matter (or pathogens) from the host.  The pathogens take 
the form of viruses, bacteria, fungi and parasites.  The immune 
system mounts an attack on these microorganisms whenever they 
trigger the appropriate mechanisms.  
Any entity possessing the ability to engage an immune response 
can be referred to as an antigen. 
Many types of cells are involved in the immune system but two 
are of particular interest to many immunologists as they play a 
pivotal role in much of the immune response. 
The T-cell (being derived in the thymus) acts to directly kill cells 
infected with viruses or activates other cells of the immune 
system.   
The B-cell (being derived in the bone marrow) secretes antibody 
which is directly and indirectly used to destroy pathogens. 
B-cells, Immunoglobulin and Antibodies 
B-cells are able to directly bind with antigen through their B-cell 
receptors or are able to secrete antibodies possessing this ability.  
The antigen-binding portion of the antibody is equivalent to the 
B-cell receptor and thus antibodies can be thought of as the 
secreted form of a B-cell receptor.   
The immune system operates by generating a large variety of 
antibodies, also known as immunoglobulins, each able to 
recognize a different antigen. 
Each B-cell generates only one form of immunoglobulin, the 
variety required by the immune system being created by the vast 
numbers of B-cells that are generated. 
Immunoglobulin molecules are roughly Y-shaped and consist of 
four polypeptide chains.  
 
Figure 1 - Immunoglobulin molecules are composed of four 
polypeptide chains; two heavy (green) and two light (yellow) 
joined by disulfide bonds (Janeway 2005) 
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Due to the relative molecular weight difference between them, the 
polypeptide chains are named heavy and light and are attached to 
each other via disulfide bonds.  
The tips of the upper two arms of the Y contain the amino acids 
that anchor the immunoglobulin to the antigen.   
In order to recognize the variety of antigens encountered by the 
host, the tips of the arms are not fixed in composition but instead 
are highly variable, allowing each immunoglobulin molecule to 
be specific for a given antigen. 
It is generally acknowledged that antigen binding occurs in a 
variety of ways and thus leads to a differing arrangement of 
antibody conformations. 
 
Figure 2 - Antigens can bind in pockets, grooves or on 
extended surfaces with antibodies. (Janeway 2005) 
Exploring these variable domains further, it can be seen that there 
are specific positions in the peptide chain in which variability is 
highest.  There are twelve such regions of hypervariability per 
immunoglobulin molecule. 
As each arm of an immunoglobulin molecule is identical, there 
are actuality only six unique hypervariable units.   
 
Figure 3 - Discrete hypervariable (HV) regions in both light 
and heavy chains (Janeway 2005) 
Each of the hypervariable regions is surrounded by less variable 
stretches, which are structurally β-sheets.   
Each of the chains contains three of the six loops that form the 
binding region.  The hypervariable portions of the loops on the 
light chain are designated L1, L2 and L3 whilst those on the 
heavy chain are H1, H2, and H3.   
These regions are also known as complementary determining 
regions (CDRs) and this term is useful when discussing the 
general mechanism of binding to antigen or the means by which 
these regions are created by the host cells. 
The CDRs of antibodies, as noted earlier, are derived from the 
combination of two chains.  This mechanism produces variability 
in relation to the binding site, seeing as combining different 
variants of the chains results in different sets of CDRs. 
Despite the large number of permutations that are afforded by this 
technique, the immune system has yet a more robust means of 
generating dramatically larger numbers of unique CDRs. 
The CDRs are generated not by a single or multiple genes, but are 
instead built from a repertoire of gene segments which are 
rearranged in a random way thus generating great diversity. 
This process alone accounts for roughly 106 different specificities 
(Janeway 2005), but in addition to this combinatorial diversity we 
need to overlay something called junctional diversity in which the 
recombination of the gene segments creates unique nucleotides 
along the splicing joints. 
In fact, H3 and L3 are significantly affected by this process since 
both of these regions are coded by a gene segment that falls 
directly on one of the junctions.  This property is manifest in 
figure 3, where greater variability is visible within these units. 
When a B-cell responds to an antigen, a process called somatic 
hypermutation commences in which point mutations are 
introduced to CDRs in an attempt to generate a higher affinity 
binding to the antigen.   
This process is subject to positive and negative selection 
pressures, and ultimately immunoglobulins that have a higher 
binding affinity to the antigen will dominate.  Possibly resulting 
in molecules that have even higher affinities then that associated 
with the original immunoglobulin that was involved in activating 
the B-cell.  
T-Cells and MHC 
T-cells are also involved in the recognition of antigen but do not 
directly attach to antigens. 
Instead T-cells recognize peptide fragments that have been 
internalized by other host cells via endocytosis, chopped into 
pieces, and subsequently exported to the cell surface. 
Besides obtaining peptide fragments from extra-cellular space, 
host cells are also able to present intercellular matter, such as 
viruses and bacteria, to the T-cells. 
The peptide pieces that are presented (also known as epitopes) are 
on the order of 10 amino acids and consist of a contiguous 
fragment of the antigen protein. 
The complex that is responsible for the presentation on the cell 
surface is called major histocompatibility matrix (MHC), the 
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genes for which are continuously active in almost every cell of 
the human body. 
Just as in the case of immunoglobulins, MHC molecules require a 
highly variable binding arrangement in order to accommodate the 
great variety of peptide fragments that may be encountered. 
While not as uniquely prolific as immunoglobulin generation, the 
MHC genes allow for a great variety of MHC molecules to be 
constructed.   
As noted earlier MHC molecules are brought to the cell surface 
where T-cells interact with the peptide fragment contained within 
the complex. 
This configuration of MHC with T-cell allows for much less 
structural diversity than is witnessed in B-cell antigen binding.  
Additionally, the requirement that peptide fragments be held and 
somewhat firmly positioned within the MHC molecule imparts a 
stronger set of structural requirements on the overall binding 
complex. 
It is for these reasons and others that will be presented shortly, 
that immunoinformatics techniques applied to T-cells and MHC 
proteins have advanced to a greater degree than those dealing 
with B-cells. 
EPITOPE PREDICTION 
One of the principal goals of informatics research in immunology 
is the development of algorithms to assist in the creation of new 
vaccines.  Reliable epitope identification via computational means 
would lessen the burden required for laboratory analysis of viral, 
bacterial and parasitic gene products.   
An informatics driven approach would allow the immunologist to 
greatly reduce the experimental work, providing a valuable 
starting point for the exploration of potential binding sites. 
In examining the nature of T-cell binding, it can be seen that the 
amino acids presented to T-cells consist of short linear peptide 
segments that have been cleaved from antigenic proteins.  
Because of the constraint that the epitopes must be linear along 
the polypeptide chain, many sequence based algorithms are 
highly applicable to T-cell investigation. 
The case is markedly different for B-cells, wherein the amino 
acids involved in the antibody-antigen binding may be very far 
away from each other in the polypeptide chain, but due to the 
folding of the protein they may be physically very close.  This 
critical dependence on the three-dimensional structure of the 
antigen makes informatics approaches to B-cell immunology 
problems much more difficult than those dealing with T-cells. 
In fact, advances surrounding T-cell epitope identification have 
already been integrated into the field of drug discovery.9     
Unfortunately, the same cannot be said for informatics techniques 
as applied to B-cell epitope identification. 
The remainder of this paper presents the computational methods 
currently employed in B-cell epitope prediction.  From this point 
forward we are dealing strictly with B-cell epitope prediction 
methods, so all uses of the term epitope refer only to B-cell 
epitope, not T-cell.   Likewise, for any other ambiguity 
encountered. 
But prior to diving into the informatics side of the field, a stronger 
appreciation of the biological basis surrounding the antigen-
antibody binding complex will prove fruitful during the 
subsequent analysis of the algorithms. 
A discussion of the CDR regions and associated antigenic sites as 
it relates to B-cell epitope prediction is first presented below. 
Antigen-Antibody Binding Complex 
An extremely detailed analysis of the 26 antigen-antibody 
complexes available at that time was performed by Macallum et. 
al 1996.   Their results highlighted the fact that the binding of 
antigen and antibody was much more complex than previously 
thought.   
The authors defined distinct classes of antibody-antigen for 
different types of molecules.  Haptens formed one group (small); 
peptides, carbohydrates and nucleic acids another (medium), and 
finally proteins in the last (large).   
Large antigens were found to contact residues at the extremities 
of the combining site along with the apical loop residues. 
Additionally and most importantly they proposed a “contact 
definition” for the interaction and in doing so redefined which 
amino acids make up the CDR positions, generally choosing to 
increase the length of the CDRs based on their analysis of the 
antibody-antigen interactions. 
More recently, it has been demonstrated (Collis et. al. 2003) that 
the mixture of lengths of the CDRs is the determining factor for 
the nature of the combination site.  Specifically, L1, L3, H2 and 
H3 play a pivotal role is this mechanism.  For example long L1, 
L2, H and H2 with a short L3 and H3 would result in a groove.  A 
long L1, H2 with a medium to long H3 and a short L3 would 
result in a pocket.  Likewise a very long H3 could be the result of 
a protuberance from the surface.  
 
 
Figure 4 - A representation of the antigen combining site and 
the associated CDR positions (Collis et. el. 2003). 
It was also found that some of CDRs were more likely to vary 
than others in length.  The authors found that for the 1788 
antibodies studied, the lengths of L1, L3, H2 and H3 appeared 
most affected by the topography of the combining site. 
An analysis of sequence composition revealed that “in all cases 
the distributions of amino acid frequencies in antibody combining 
sites were totally different from that of normal loops.” 
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The above result has significant impact on the ability to predict 
epitopes, as one cannot make hypotheses regarding the combining 
site based on the distributions found in unbound antigen-antibody 
complexes.  That is, the proteins should only be examined when 
they are bound together. 
Additionally, as is pointed out by van Regenmortel (2006), some 
of antibody-antigen interactions that are being used for study may 
in fact be artifacts of the process in which they were obtained. 
The assay in which the antigen was prepared might contain 
denatured molecules and in doing so create conditions for a 
binding site that would not be available in-vivo.   This has been 
shown in the unique forms of binding that occur when an 
antibody recognizes a peptide in free solution as opposed to 
conjugation with a carrier or absorbed as a solid phase.  
Further exploration of 59 antigen-antibody interactions was 
performed by Almagro 2004 with the intention of identifying and 
characterizing the CDR residues that directly interact with the 
antigen; the so called specificity determining residues (SDRs). 
The observations were mostly in agreement with that of 
Macallum et. al., 1996, with only minor differences in the 
locations of the CDR regions. 
Now that the biological basis surrounding B-cell antigen-antibody 
biding has been elucidated, we can turn our attention to the in-
silico prediction techniques which have accompanied these 
discoveries. The techniques are presented in chronological order 
so that an appreciation of the advancement in the field can be 
obtained.   
B-CELL EPITOPE PREDICTION  
Immunologists, inspired by the success of informatics as it was 
applied to the human genome, turned to similar algorithms in 
order to solve the epitope prediction problem. 
One of the early and most influential papers on epitope prediction 
(Hopp and Woods 1981) devised a method based on the 
observation that charged hydrophilic amino acids are common 
features of antigen determinants.  They used a combination of 
Chou and Fastman’s 1974 technique of averaging values across a 
polypeptide chain with the solvent parameters, obtained from 
Levitt 1976.   
Curiously, they adjusted the values obtained from Levitt in order 
to build a model that had a higher success rate.  But of course in 
doing so, they then lacked a control set of data over which to 
verify the validity of the model.   
The conclusion of the authors was a 100% success rate out of the 
12 proteins that formed the data set.   It would have been most 
interesting to build the model on six of the proteins and then 
attempt to predict the other six, but unfortunately it would take 
another ten years for this to happen. 
A full review of epitope prediction as was current for the time 
was presented by Pellequer et al. 1991.  Many of the propensity 
scales in use at the time were compared, Hopp included, against 9 
extensively studied epitopes from 11 proteins.  The results 
demonstrated a very low success rate using any of the techniques 
described in the paper.   It was also pointed out that many of the 
techniques were widely popular at the time and that numerous 
authors reported high success rates.  It is most likely that these 
high reported success rates are possibly attributed to small 
datasets and a prevalence of skewed testing methodologies, as 
will be described later.  
Interesting, though, the most striking comment from the authors 
apparently would not be fully appreciated for yet another 10 
years. 
“These globally mediocre results reflect the fact that 
no single scale contains enough information to allow 
a transformation from primary structure data to a 
tertiary structure entity (the epitope).  Clearly, 
available prediction methods based on unidirectional 
analysis do not cope satisfactorily with the three-
dimensional reality of antigenic sites.” 
Despite the authors compelling arguments which included data 
from other papers showing a 52-61% success rate and noting that 
that at the time only 26 complexes were available for study, the so 
called one-dimensional techniques would continue to be explored 
for many years. 
The debate of epitope prediction using one dimensional sequence 
analysis (as termed by van Regenmortel 1996) continued with 
even more fervor as van Regenmortel implied that even a three 
dimensional model would be insufficient for correct prediction as 
the antigen-antibody interaction is a dynamic event with time, the 
fouth-dimension, entering the equation.  
A terse two page article appearing in Protein Science (Blythe & 
Flower 2005) provided extremely compelling evidence on the 
futility of using amino acid scales to derive epitope predictions.  
The authors examined 50 proteins using 484 unique amino acid 
scales with 17,100 combinations of algorithm parameters.  After 
choosing the 150 most likely candidates a further 228,900 
parameter combinations were performed.  They concluded that 
there was no significant correlation between the sequence profiles 
and the location of known epitopes.  Clearly, the technique of 
epitope prediction must include more than just statistical data 
about polypeptide strands. 
It may be co-incidence, but it appears that after the publication of 
this paper there has been an expansion in the number of novel 
techniques being applied to the problem of epitope prediction. 
The CEP prediction server (Kulkarni-Kale et. al. 2005) 
introduced the concept of “accessibility of residues” based on a 
metric computed using the three dimension nature of the antigen.  
This approach was reported to achieve a 75% correct prediction 
rate, based on 21 complexes.  The authors acknowledge in their 
paper that even approximate prediction is useful in helping to 
design experiments and that their technique locates probable 
antibody-antigen binding sites. 
More recently, the CEP server (accessed March 2007; web site 
last updated August 2006), reports 52 complexes showing 39 
correctly predicted.  Wherein a correct prediction is yielded if 
>60% of the residues identified match the known binding sites.    
The epitope mapping tool (EMT) described by Batori et. al. 2006, 
was constructed around a database of antibody motifs.  These 
1502 5-10 segment long amino acid sequences were classified 
into general motifs by sequence alignment.  The authors do not 
specify what algorithm was used to do the alignment nor the 
criteria of what constitutes a motif.   A single antigen was 
presented against the model and the authors reported that there is 
favorable evidence of the existence of epitope motifs.   
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It would be interesting to see how the hypothesis fairs under the 
stress of more than a single antigen. 
Machine-learning techniques are also just now being applied to 
this problem, apparently in hopes that one of them will provide 
positive results. 
An artificial neural network (Saha & Raghava, 2006) appears to 
have produced slightly better results than the ‘classical’ 
propensity scales approach.   An accuracy rate of 66% was 
achieved by the authors which is somewhat marginally better than 
prior prediction attempts.  Besides being the first application of a 
neural net to this problem domain, what is notable about this 
study is the testing methodology.  A dataset consisting of an equal 
number of known epitopes and non-epitopes were chosen.   
This appears to be the first instance with B-cell epitope predictors 
in which know negatives have been inserted into the dataset.  
Additionally, the authors randomly chose three-fifths of the set 
for training; leaving the remaining two-fifths for validation and 
testing.  This process was then repeated five times and the final 
results were obtained from an averaged of the testing sets.  This 
exemplary use of blind and randomized testing will hopefully 
become the norm for the validation of epitope predictors. 
The use of hidden Markov models (HMMs) was also recently 
explored by Larsen et. al. 2006. A combination of propensity 
scales and HMM trained on epitopes, reported to result in slightly 
better performance than previous methods.    
Undeterred by Blythe and Flower’s compelling paper, a 
subsequent effort by Anderson et. al. 2006, chose to combine 
propensity scale metrics with the effects of spatial proximity and 
surface exposure.  Choosing to incorporate some amount of three 
dimensional criteria in their scale was wise, but apparently 
insufficient to produce any significant advantage when compared 
against earlier techniques. 
Epitope Interaction Databases 
One of the issues with epitope prediction is that there is no 
consensus on what interactions are antigenic.  Thus comparing 
techniques is difficult, even those that work against the same 
protein (Schlessinger et.  al. 2006).   
The construction of an antigen-antibody database is one means to 
alleviate this issue, as there would be a consistent definition of 
what constitutes a binding complex for a given antigen.  Epitome, 
Bcipep and AntiJen are examples of such efforts.   
The goal of the Epitome (Schlessinger et. al. 2006) database is to 
categorize all known antigen-antibody complexes in the PDB.  A 
semi-automatic process produces a detailed description of the 
CDRs and the antigenic residues.  One interesting note about this 
approach is that the authors choose to use a structural alignment 
tool (SKA) to perform the initial step of locating the CDRs.  
Curiously, the authors noted that usage of sequence similarity is 
problematic when applied to CDR detection, yet they choose to 
use a structure alignment tool as part of the first phase of 
antibody-antigen analysis. 
CDRs are highly variable by definition and structural alignment 
programs work by locating regions of similarity, one wonders 
about the efficacy of this approach.  It is quite possible that using 
this approach all interaction sites were located with the currently 
know complexes, but as the authors are intent on automating the 
entire process, it is quite conceivable that a new form of antigen 
variant will be encountered.  This approach would then possibly 
fail to locate this new pattern. 
An alternative technique would be to utilize the fact that 
immunoglobulin is involved in all these interactions in only a 
limited region of the entire protein.   One could use this biological 
fact to narrow the search down to only the loops of the antibody.  
The PDB structures could then be directly interrogated to identify 
which amino acids are in reasonable proximity to the antigen, thus 
determining which peptides are likely involved in the complex.   
The benefit of this approach is that the full resolution of the three 
dimensional relationship between antigen and antibody is utilized 
to determine the combining site.   Additionally, as new and 
possibly unique antigen-antibody complexes are encountered, this 
method would remain viable. 
In any event, it is quite disappointing that the implementation 
abandons the information rich, three-dimensional data contained 
within the PDB so early during the processing. 
The Antijen database (Blythe et. al. 2002) is the most extensive 
epitope database with over 24,000 entries.  Although, it contains 
peptide binding data for a number of interactions including B-cell 
epitopes, the main focus of the resource is linear epitopes.   
Bcipep (Saha et. al. 2005) contains B-cell epitope data derived 
from 1216 antigens described in PDB.  This database also 
exclusively focuses on linear epitopes. 
The Immune Epitope Database (IEDB) contains a highly 
annotated set of B-cell epitopes that have been curated from PDB 
antigen-antibody complexes.  Currently an effort is underway to 
provide a non-redundant set of data that is tailored for use with 
epitope prediction tools (Sette, A. unpublished work).  These 
datasets should be available by mid-2007. 
All of these efforts will hopefully lay the groundwork for a 
unified, consistent and controlled series of datasets that can be 
utilized for building, testing and comparing predictors. 
NEW DIRECTIONS 
The influence of antibody structure on function cannot be 
understated in the context of antigen-antibody interaction. 
Epitopes are highly context dependent and cannot exist without a 
corresponding antibody.  At the same time, the presence of 
somatic hypermutation results in variations at the binding site.  It 
is therefore more apropos to regard the antigenic surface as a 
landscape of epitopic regions without well defined borders 
(Greenbaum et. al. 2006).   
Given the right set of circumstances any region on the surface can 
act as a binding site and therefore an enormous number of 
epitopes exist for a given antigen.  The difficulty with this 
definition is that tools that choose to divide regions into epitopes 
and non-epitopes may therefore not reflect the biological reality 
of the situation.  And in doing so, are then prone to produce 
inaccurate and incomplete epitope predictions. 
For these reasons an epitope prediction algorithm must be based 
on the structure of the antigen first and foremost.  The particular 
amino acids at a given position on the polypeptide chain of an 
antigen are somewhat immaterial when first considering a binding 
complex.  Instead they should be viewed as of a consequence of 
the three dimensional activity of a docking event.  Characterized 
in these terms, it is clear that the structure of the antigen is 
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paramount and should be considered the foundation of any 
prediction tool. 
So far, B-cell epitope related studies of antigen-antibody binding 
sites have focused on amino acid sequence, gross patterns of 
antigen surface topology or some combination of the two.   All 
attempts, thus far, to use the information derived from these 
studies has resulted in very poor epitope predictors. 
It appears that in attempts to reduce the complexity of the 
antigen-antibody interaction, vital information is lost.  Thus, it 
may be worthwhile to tackle the problem in a completely different 
manner.  
One possibility is to explore the antigen-antibody interaction as a 
fully three dimensional physical entity similar in fashion to how 
an antibody ultimately binds with an antigen.  Calculating the 
atomic forces that come into play within the antigen-antibody 
binding site and then performing a statistical analysis across a 
number of known antigen-antibody complexes, might reveal some 
hitherto unknown aspect of the interaction.   
Using this approach one could imagine a catalog (similar to 
motifs) of molecular force patterns that signify a strong 
correlation with a potential epitope; the catalog, being built from 
known antigen-antibody complexes.  Upon presentation of a new 
antigen the force fields would be computed for the entire protein 
and then the catalog searched for a similar field configuration. 
The next step of presenting an antibody complex could also be 
computed.  As the antigen site is located, a number of potential 
CDR configurations and amino acid sequences could be built up 
using charge information from the potential binding locations.  
Each of these antibodies could then be placed in a molecular 
dynamics simulation with only the relevant portions of the 
molecule involved being part of the computation.  The binding 
state (or lack thereof) could then be modeled to high degree of 
accuracy.   This approach would also allow for the proteins to be 
placed in solute so that the interactions of the surrounding 
medium could also be taken into account.   
Although solving a related but somewhat different problem, 
Cachau et. al. 2003, utilized molecular modeling techniques to 
map peptide sequences to three dimensional structures.  So, the 
use of physical models has some grounding and is not completely 
foreign for this endeavor. 
The use of molecular modeling techniques as applied to this 
problem domain may seem like a radical approach and quite 
possibly there is little expertise in the immunoinformatics arena 
with this technology, but in order to make any advancement in 
epitope prediction some fundamentally new idea is required.  The 
techniques so far employed have achieved little advancement in 
this area over the last 15 years, so it is clear that the assumptions 
upon which these models are built are flawed and something 
entirely new needs to be tried. 
CONCLUSION 
I have presented the current state of immunomics techniques 
applied in the B-cell epitope discovery problem and have 
provided the underlying biological framework in which to 
evaluate the effectiveness of each of these approaches. 
While the field of T-cell epitope prediction has made some 
significant advances, unfortunately despite much effort and 
activity the same cannot be said of B-cell prediction.9   
This is most likely due to the fact that many of the ubiquitously 
available genomics tools / algorithms are applicable for T-cell – 
MHC binding, but that interactions associated with the possibly 
seemly related antigen-antibody binding problem are significantly 
more complex. 
Ample evidence was provided that these two types of binding are 
indeed distinct and that similar algorithmic approaches cannot be 
utilized.  
A critique of the current techniques being applied to the problem 
of B-cell epitope prediction was also presented. Notes for 
potential improvement opportunities were set forth, as the 
discussion warranted. 
Finally, a radically new approach of B-cell epitope 
characterization and prediction, based upon molecular mechanics, 
was elucidated.  This technique fully takes account the three-
dimensional molecular nature of an antigen-antibody interaction.  
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